XML 30 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash Flows from Operating Activities    
Net loss $ (12,974,799) $ (21,121,885)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 132,077 115,307
Amortization of deferred financing costs and debt issuance costs 218,827 101,563
Amortization of held to maturity investment premium 32,733 142,442
Stock based compensation 582,630 1,573,602
Increase (decrease) in cash arising from changes in assets and liabilities:    
Accounts receivable (82,440)
Prepaid expenses, restricted cash, and other current assets 532,872 (32,088)
Deposits (50,000)
Related party receivable (45,000) (9,375)
Accounts payable (1,690,048) 642,332
Accrued expenses and other liabilities (542,255) 1,040,939
Other long term liabilities 311,686 149,748
Net Cash Used in Operating Activities (13,523,717) (17,447,415)
Cash Flows from Investing Activities    
Proceeds from maturities of short-term investments 6,656,910 14,956,988
Purchases of short term investments (11,090,091)
Purchase of property and equipment (45,936) (115,506)
Net Cash Provided by Investing Activities 6,610,974 3,751,391
Cash Flows from Financing Activities    
Proceeds from public offering, net of underwriting discounts 6,287,250 11,400,870
Proceeds from the issuance of common stock, net of commissions 7,082,526
Proceeds from the exercise of warrants 3,863,429
Stock issuance costs (488,585) (302,460)
Proceeds from issuance of long term debt, net 4,470,975
Payments on long term debt (6,941,821) (558,179)
Net Cash Provided by Financing Activities 9,802,799 15,011,206
Effect of exchange rate changes on cash and cash equivalents 12,656 (89,531)
Net Increase in Cash and Cash Equivalents 2,902,712 1,225,651
Cash and Cash Equivalents - Beginning of Period 4,939,955 3,714,304
Cash and Cash Equivalents - End of Period 7,842,667 4,939,955
Supplemental Disclosure for Cash Flow Information    
Interest paid 330,576 262,066
Supplemental Schedule of Noncash Investing and Financing Activities    
Cashless exercise of stock options $ 32,588